/enri-thumbnails/careeropportunities1f0caf1c-a12d-479c-be7c-3c04e085c617.tmb-mega-menu.jpg?Culture=en&sfvrsn=d7261e3b_1)
/cradle-thumbnails/research-capabilities1516d0ba63aa44f0b4ee77a8c05263b2.tmb-mega-menu.jpg?Culture=en&sfvrsn=1bc94f8_1)
7e6fdc03-9018-4d08-9a98-8a21acbc37ba.tmb-mega-menu.jpg?Culture=en&sfvrsn=7deaf618_1)
CI Programmes
The NHG CMTi Clinician Innovator Preparatory Programme (CiPP) aims to introduce clinicians to the foundational skills and knowledge required for health technology (HealthTech) innovation through innovation training and project experience, as well as to foster a healthy innovation culture in NHG.
ELIGIBILITY CRITERIA
Applicants should be:
a) Doctors (i.e. clinically qualified with MD/MBBS/BDS) with primary appointments at NHG institutions;
OR
b) Health science / healthcare professionals with non-medical degrees, such as nurses, pharmacists and other allied health professions with primary appointments at NHG institutions.
All applicants should also fulfil the following criteria:
a) Demonstrate interest in HealthTech innovation and intention to develop himself/herself as a Clinician Innovator (CI) but have little or no innovation experience;
b) Able to commit time to complete the required courses under the CiPP training curriculum and project within the award period;
c) Applicants are recommended to commit an estimated 0.1FTE to complete their innovation project within the award period, with the approval from their Reporting Officer.
The proposed project:
a) Must be a HealthTech product innovation project that aims to potentially address unmet clinical needs in healthcare
(Note: Scope of proposals pertaining to the development of new software (e.g. digital apps, artificial intelligence for diagnosis and/or intervention, etc.) shall be limited up to prototyping and pre-clinical testing (i.e. inclusion of clinical trials involving patient data is not allowed);
b) Must be a project with specific aims that can be achieved within the award quantum;
c) Should have a realistic timeline that ensures that applicable ethics approval(s), finalisation and execution of relevant agreements, and set deliverables can be completed within the award term;
d) Must specify the plans for obtaining follow-up grants for subsequent Proof of Concept and/or Proof of Value.
Applicants are to ensure that the appropriate collaborator(s) essential to technology development for their proposed project, are secured where required, before submitting an application. Applicants may reach out to NHG CMTi for assistance in matching of collaborator(s).
Interested clinicians are strongly encouraged to contact the CiPP Secretariat for discussion on suitability of the programme prior to submitting an application.
COACHING SESSION
To provide support for applicants in scoping their projects and for feedback on their proposals, there will be coaching sessions held during the Call period. All applicants are encouraged to register for this session with NHG CMTi as soon as there is interest to submit an application and at least 2 weeks prior to the call deadline. Registration is on a first-come-first serve basis and timeslots are subjected to the coaches’ availabilities. Register for a coaching session here or scan the QR code.
If the proposed project encompasses a software/digital technology component, applicants are required to complete the e-learn module on eLEARN prior to the coaching session for a more fruitful discussion. Please follow the steps to access the module:
- Log into your eLEARN account at https://elearn.sg/nhg/Login
- Select “Marketplace”
- Search “Digital Health Applications (DHA) Clinic”
- Select “Register” to enrol and complete the module
AWARD COMPONENTS
Awardees are required to complete the programme within two years.
MENTORSHIP
Each applicant is required to nominate a mentor who is an institution representative on the NHG CMTi Committee (refer to Information Sheet). The CiPP Secretariat may help to facilitate the matching of appropriate mentor if required.
Each applicant will receive mentorship in the following areas:
a) Guidance in their clinician innovator career development
b) Advice on their innovation project
c) Navigation to appropriate innovation resources
d) Engagement in institution or NHG cluster level innovation activities and initiatives
Applicants may propose other qualified NHG mentor(s) that is not part of the NHG CMTi Committee, with justifications and, subject to approval.
During the award, awardees will be granted access to the subject matter experts on an adhoc basis in area(s) of their own interest. Proposed topic areas may include venture building, medical technology development cycle, medical device regulatory affairs, intellectual property, etc. This will be subsequently facilitated by NHG CMTi.
APPLICATION PERIOD
Applicants are required to submit all application documents (Table 1) in softcopy to the CiPP Secretariat at NHG Group Research through their Institution’s Clinical Research Unit / Clinical Research and Innovation Office (CRU/ CRIO).
The Institution’s CRU/ CRIO will set an internal deadline for the above submission, and ensure that the documents reach the CiPP Secretariat by the stipulated deadline. Please check with your institutions for the deadline. Applications submitted after the call closing date and time will not be considered.
FY2024 NHG CMTi CiPP Information Sheet
This document contains important information about the objective of the programme, award components, eligibility, application procedure, evaluation criteria and expected deliverables etc., and should be read carefully before proceeding to apply.
Please click here to download the Information Sheet.
FY2024 NHG CMTi CiPP+ Information Sheet
This document contains important information about the objective of the programme, award components, eligibility, application procedure, evaluation criteria and expected deliverables etc., and should be read carefully before proceeding to apply.
Please click here to download the Information Sheet.
CONTACT INFORMATION
For more information and further enquiries, please contact the CiPP Secretariat:
Ms Adeline Chan
Clinician Scientist Development Office
NHG Group Research
Tel: (65) 6340 2414
Email: [email protected]
Ms Valerie Yeo
Clinician Scientist Development Office
NHG Group Research
Tel: (65) 6496 6021
Email: [email protected]
The NHG CMTi Clinician Innovator Preparatory Programme Plus (CiPP+) aims to encourage clinicians to participate in Health Technology (HealthTech) innovation to improve healthcare delivery and outcomes for their patients. The programme would also prepare them to compete successfully for the Singapore Biodesign (SB) Innovation Fellowship Programme or National Medical Research Council (NMRC) Transition Award (TA) / Clinician Innovator Award (CIA) within the next 2-3 years and further build his/her career in HealthTech innovation.
ELIGIBILITY CRITERIA
1. Applicants should be:
a) Doctors (i.e. clinically qualified with MD/MBBS/BDS) with primary appointments at NHG institutions;
OR
b) Health science / healthcare professionals with non-medical degrees, such as nurses, pharmacists and other allied health professions with primary appointments at NHG institutions.
2. All applicants should also fulfil the following criteria:
a) Have completed the NHG Clinician Innovator Preparatory Programme (CiPP) or demonstrate equivalent level of competency in foundational training in HealthTech innovation
b) Is a clinician Principal Investigator (PI), Co-PI or Co-Investigator (Co-I) of an ongoing or new HealthTech innovation project that has been awarded or pending outcomes of competitive grant funding1; and/or is in collaboration with industry partner(s).
The project or grant term must have at least one year remaining at the point of CiPP+ application without a request for grant extension.
c) Demonstrate interest in HealthTech innovation and intention to develop himself/herself as a Clinician Innovator (CI).
3. Awardees and applicants of NMRC Human Capital Awards and Talent Development
Programmes such as Transition Award (TA), Clinician Innovator Award (CIA), Clinician Scientist Award (CSA), HPHSR CSA (HCSA) and Singapore Translational Research Investigator Award (STaR), will not be eligible for the CiPP+.
4. As awardees are expected to apply for the Singapore Biodesign (SB) Innovation Fellowship Programme or equivalent, NMRC TA or CIA within one year from the end of their CiPP+ award period, applicants should ensure they are able to fulfil the latest eligibility criteria for the respective programme.
5. The applicant’s Department should be able to make provisions for the applicant’s commitments towards HealthTech innovation during the CiPP+ award period (if awarded), and continue to facilitate his/her career pathway as a Clinician Innovator beyond the CiPP+ award.
1 Examples of eligible funding sources, not limited to but including:
• National Health Innovation Centre Singapore (NHIC) – Innovation to Develop (I2D), Innovation to Industry (I2I), Innovation to Startup (I2Start)
• Agency of Science, Technology & Research (A*STAR) – Biomedical Engineering Programme (BEP)
• Singapore-MIT Alliance for Research & Technology (SMART) – Innovation Grant
• Enterprise Singapore (ESG) – Startup SG Tech (SSG Tech), Enterprise Development Grant (EDG)
• NHG Joint Grants e.g. NHG-LKCMedicine ALIVE Serious Games Grant (SSG), NHG CMTi-NHIC Joint MedTech Grant
• Other Cluster/ Institutional-level Grants e.g. NHG CMTi MedTech Grant, Ng Teng Fong Healthcare Innovation Programme (NTF HIP) Funding, Rapid Prototyping Grant, Small PROjects Utilising Teams (SPROUTS) Grant, etc.
AWARD COMPONENTS
1. Each awardee will receive a funding quantum up to S$40,000, for up to 2 years to cover:
a) Salary support for innovation of up to 0.1 FTE, with an applicable annual salary cap by clinician’s clinical designation (Table 1);
- NHG Host Institution will need to top up the difference if the awardee’s salary exceeds the applicable annual salary cap.
- Salary support will cover the total annual compensation, inclusive of salaries, CPF, fringe benefits, as well as bonus / incentive payments.
b) Local or overseas conferences/ trainings and related travel expenses;
c) Services and expertise related to the innovation project such as biostatistics, bioinformatics, data analysis and management; and/or
d) Other related support costs that help in the innovation project.
2. The CiPP+ funding is not applicable to cover any direct costs related to the innovation project or routine clinical care or services.
3. There should be an ongoing innovation project for the CiPP+ award to apply. At point of CiPP+ award announcement:
• For projects that are ongoing/have started, awardees may determine the preferred start date within 3 months from award announcement;
• For projects pending grant application outcomes, award commencement will be aligned with subsequent start date of collaboration / project agreement.
4. The funding would cease once the innovation collaboration / project agreement term ends or upon the 2-year award period, whichever is earlier. Award renewal is generally not allowable.
MENTORSHIP
Each applicant is required to nominate a mentor who is an institution representative on the NHG CMTi Committee (refer to Information Sheet). The CiPP Secretariat may help to facilitate the matching of appropriate mentor if required.
Each applicant will receive mentorship in the following areas:
a) Guidance in their clinician innovator career development
b) Advice on their innovation project
c) Navigation to appropriate innovation resources
d) Engagement in institution or NHG cluster level innovation activities and initiatives
Applicants may propose other qualified NHG mentor(s) that is not part of the NHG CMTi Committee, with justifications and, subject to approval.
During the award, awardees will be granted access to the subject matter experts on an adhoc basis in area(s) of their own interest. Proposed topic areas may include venture building, medical technology development cycle, medical device regulatory affairs, intellectual property, etc. This will be subsequently facilitated by NHG CMTi.
APPLICATION PERIOD
The Call for Applications is open throughout the year. Please contact the CiPP Secretariat to indicate your interest in applying for the CiPP+ and to obtain the application package.
Interested clinicians are strongly encouraged to contact the CiPP Secretariat for discussion on suitability of the programme prior to submitting an application.
FY2023 NHG CMTi CiPP+ Information Sheet
This document contains important information about the objective of the programme, award components, eligibility, application procedure, evaluation criteria and expected deliverables etc., and should be read carefully before proceeding to apply.
Please click here to download the Information Sheet.
CONTACT INFORMATION
For more information and further enquiries, please contact the CiPP Secretariat:
Ms Adeline Chan
Clinician Scientist Development Office
NHG Group Research
Tel: (65) 6340 2414
Email: [email protected]
Ms Valerie Yeo
Clinician Scientist Development Office
NHG Group Research
Tel: (65) 6496 6021
Email: [email protected]